Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04663997
Title 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Vancouver Cancer Centre Vancouver British Columbia V5Z 4E6 Canada Details
London Regional Cancer Program London Ontario N6A 5W9 Canada Details
Odette Cancer Centre Toronto Ontario M4N 3M5 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
CHUM-Centre Hospitalier de l'Universite de Montreal Montreal Quebec H2X 3E4 Canada Details
The Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Hotel-Dieu de Quebec Quebec City Quebec G1R 2J6 Canada Details
CIUSSS de l'Estrie - Centre hospitalier Sherbrooke Quebec J1H 5N4 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field